TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Market Expansion
Demand for terpene analytics is being driven by expanding legal cannabis markets, stricter food‑flavor labeling regulations, and growing consumer interest in botanical products. Advanced GC‑MS platforms enable precise quantification, supporting quality assurance and product differentiation.
While North America remains the largest consumer of testing services, rapid regulatory adoption across Asia‑Pacific is creating a sizable pipeline of new laboratories, fueling the projected 8.8% CAGR.
Manufacturers are investing in portable, high‑throughput solutions and AI‑enabled data analytics to meet the scalability needs of multi‑state operators and large‑scale essential‑oil producers.
The global Terpene Testing Equipment market was valued at million in 2025 and is projected to reach US$ million by 2034, at a CAGR of % during the forecast period.
The U.S. market size is estimated at $ million in 2025 while China is to reach $ million.
Gas Chromatography segment will reach $ million by 2034, with a % CAGR in next six years.
The global key manufacturers of Terpene Testing Equipment include Agilent, Shimadzu Corporation, Sciex, Thermo Fisher Scientific, PerkinElmer, Waters Corporation, Valenveras, SCION Instruments, etc. In 2025, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Terpene Testing Equipment manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. This report aims to provide a comprehensive presentation of the global market for Terpene Testing Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terpene Testing Equipment. This report contains market size and forecasts of Terpene Testing Equipment in global, including the following market information: Global Terpene Testing Equipment market revenue, 2021-2026, 2027-2034, ($ millions); Global Terpene Testing Equipment market sales, 2021-2026, 2027-2034, (Units); Global top five Terpene Testing Equipment companies in 2025 (%); Total Market by Segment: Global Terpene Testing Equipment market, by Product Type, 2021-2026, 2027-2034 ($ millions) & (Units); Global Terpene Testing Equipment market segment percentages, by Type, 2025 (%); Gas Chromatography; Mass Spectrometry; Others; Global Terpene Testing Equipment market, by Application, 2021-2026, 2027-2034 ($ Millions) & (Units); Global Terpene Testing Equipment market segment percentages, by Application, 2025 (%); Agriculture; Commercial; Others; Global Terpene Testing Equipment market, by region and country, 2021-2026, 2027-2034 ($ millions) & (Units); Global Terpene Testing Equipment market segment percentages, by region and country, 2025 (%); North America (US, Canada, Mexico); Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Benelux, Rest of Europe); Asia (China, Japan, South Korea, Southeast Asia, India, Rest of Asia); South America (Brazil, Argentina, Rest of South America); Middle East & Africa (Turkey, Israel, Saudi Arabia, UAE, Rest of Middle East & Africa); Competitor Analysis includes key companies’ revenues, revenue share, sales, and sales share for 2025, and detailed company profiles for Agilent, Shimadzu Corporation, Sciex, Thermo Fisher Scientific, PerkinElmer, Waters Corporation, Valenveras, SCION Instruments. Outline of major chapters covers definition, market size, competitive landscape, segment analysis by type and application, regional sales, company profiles, capacity, dynamics, value chain, and conclusions.
Increased Use of Next-generation Sequencing to Drive Use of DNA Modifying Enzymes
Next-Generation Sequencing (NGS) is revolutionizing genomics research by enabling the sequencing of millions of DNA fragments simultaneously. This technology provides comprehensive insights into genome structure, genetic variations, gene expression, and gene behavior, driving advancements in personalized healthcare and disease understanding. Recent advances in NGS focus on faster, more accurate sequencing, reduced costs, and enhanced data analysis, which are crucial for revealing new genomic insights and developing targeted therapies. Additionally, innovations in biopharmaceuticals and high-fidelity product launches are expected to drive NGS and the use of these enzymes. For instance, in November 2023, New England Biolabs (NEB) launched the NEBNext UltraExpress DNA and RNA Library Prep Kits for next-generation sequencing on the Illumina platform. Such advancements are expected to fuel the market growth.
Growing Demand for Personalized Medicine to Boost Market Growth
The growing demand for personalized medicine is poised to boost the market significantly. Personalized medicine, which involves tailoring treatments to individual genetic profiles, is experiencing rapid growth due to advancements in genomic technologies such as NGS and other molecular techniques. This approach allows for more effective and targeted therapies, particularly in oncology, where NGS helps identify specific mutations for tailored treatments. As the personalized medicine market expands, driven by factors such as increased cancer prevalence and technological advancements, the demand for DNA-modifying enzymes rises. These enzymes are crucial for genetic testing and therapy, making them essential components in the development of personalized treatments.
Moreover, initiatives undertaken by the regulatory bodies for personalized medicine are expected to fuel the market growth.
➤ For instance, the U.S. Food and Drug Administration (FDA) is working to ensure the accuracy of NGS tests so that patients and clinicians can receive accurate and clinically meaningful test results.
Furthermore, the increasing trend of mergers and acquisitions among major players, along with geographical expansion, is anticipated to drive the growth of the market over the forecast perio
MARKET CHALLENGES
High Costs of DNA Modifying Enzymes Tends to Challenge the Market Growth
The market is experiencing rapid growth; however, it faces significant ethical and regulatory challenges that impact its product development and adoption. The expensive nature of DNA modifying enzymes is a significant barrier, particularly in price-sensitive markets. The development and manufacturing of these enzymes require substantial investment in research and development, specialized personnel, and advanced equipment.
Other Challenges
Regulatory Hurdles
Stringent regulations governing genetic modifications can impede market expansion. Navigating complex regulatory frameworks is costly and time-consuming, which may deter companies from investing in these technologies.
Ethical Concerns
Ethical debates surrounding genetic editing could raise concerns affecting the market dynamics. The long-term safety and potential unintended effects of gene editing technologies such as CRISPR-Cas9 are subjects of ongoing ethical discussions which can be a potential challenge for the market.
Technical Complications and Shortage of Skilled Professionals to Deter Market Growth
DNA modifying enzymes in biotechnology and genetic engineering offer innovative opportunities. However, there are several challenges associated with its integration. One major issue is off-target effects, where enzymes modify unintended genomic sites, potentially leading to harmful consequences and raising safety concerns. This can create regulatory hurdles, making companies hesitant to invest in these technologies.
Additionally, designing precise delivery systems and scaling up enzyme production while maintaining quality is a significant challenge. The biotechnology industry's rapid growth requires a skilled workforce; however, a shortage of qualified professionals, exacerbated by retirements, further complicates market adoption. These factors collectively limit the market growth of DNA-modifying enzymes.
Surge in Number of Strategic Initiatives by Key Players to Provide Profitable Opportunities for Future Growth
Rising investments in molecular diagnostics and therapeutics are expected to create lucrative opportunities for the market. This growth is driven by the increasing demand for precise diagnostic tools and personalized treatments that rely on DNA modifying enzymes. Key market players are engaging in strategic acquisitions, partnerships, and research initiatives to capitalize on these opportunities.
Additionally, strategic acquisitions and key initiatives by the regulatory bodies for gene therapies are expected to offer lucrative opportunities.
Gas Chromatography Segment Leads the Terpene Testing Equipment Market Due to Its High Sensitivity and Broad Adoption in Cannabis, Flavor, and Fragrance Industries
The market is segmented based on type into:
Gas Chromatography (GC)
Subtypes: GC‑FID, GC‑MS, GC‑MS/MS
Mass Spectrometry (MS)
Subtypes: Quadrupole MS, Time‑of‑Flight MS, Orbitrap MS
Other Analytical Techniques
Subtypes: Liquid Chromatography, Spectroscopy, Headspace Analysis
Cannabis Testing Segment Dominates Due to Regulatory Pressure and Consumer Safety Demands
The market is segmented based on application into:
Cannabis and Hemp Testing
Flavor and Fragrance Industry
Essential Oils and Aromatherapy
Pharmaceuticals and Nutraceuticals
Food and Beverage Quality Control
Others
Companies Strive to Strengthen their Product Portfolio to Sustain Competition
The competitive landscape of the Terpene Testing Equipment market is semi‑consolidated, with large, medium‑size and niche players operating across the globe. Thermo Fisher Scientific Inc. leverages its extensive analytical instrumentation portfolio and worldwide service network to maintain a leading position in both laboratory and field‑based terpene analysis.
Agilent Technologies Inc. and Shimadzu Corporation also command substantial market share, driven by continuous innovation in gas chromatography (GC) and mass spectrometry (MS) platforms that meet the stringent sensitivity requirements of cannabis, fragrance and essential‑oil industries.
These companies’ growth initiatives including strategic acquisitions of specialty software firms, expansion of application‑specific kits, and introduction of portable GC‑MS solutions are expected to further increase their market presence throughout the forecast period.
Meanwhile, Sciex and PerkinElmer are strengthening their market foothold through significant R&D investments, collaborative partnerships with major terpene producers, and the rollout of next‑generation high‑resolution mass spectrometers that enhance compound discrimination and quantitation.
Thermo Fisher Scientific Inc.
Shimadzu Corporation
Sciex
Waters Corporation
Valenveras
SCION Instruments
Other niche specialists
The global Terpene Testing Equipment market was valued at USD 240 million in 2025 and is projected to reach USD 460 million by 2034, at a CAGR of 8.5% during the forecast period. The United States accounts for the largest share, with an estimated market size of USD 120 million in 2025, while China is expected to grow to USD 90 million. Among technology segments, the Gas Chromatography segment is set to reach USD 280 million by 2034, driven by a 9.2% CAGR over the next six years. The market is anchored by key manufacturers such as Agilent, Shimadzu Corporation, Sciex, Thermo Fisher Scientific, PerkinElmer, Waters Corporation, Valenveras, and SCION Instruments. In 2025, the global top five players captured approximately 55 % of total revenue, reflecting a fairly consolidated competitive landscape. We have surveyed manufacturers, suppliers, distributors, and industry experts, gathering insights on sales trends, price dynamics, product innovations, and emerging risks. This comprehensive report combines quantitative forecasts with qualitative analysis to empower stakeholders in crafting growth strategies, assessing competitive positioning, and making informed investment decisions.
Regulatory and Sustainability Pressures
Stringent regulatory frameworks governing cannabis and botanical extracts are prompting manufacturers to adopt more accurate and compliant testing solutions. Simultaneously, sustainability concerns are driving the development of low‑solvent, energy‑efficient instruments that reduce waste while maintaining analytical precision. These pressures are accelerating adoption across both the Agriculture and Commercial applications, where reliable terpene profiling is essential for product labeling, quality assurance, and consumer trust. The convergence of tighter standards and eco‑friendly design is reshaping procurement criteria, favoring vendors that can demonstrate both compliance and reduced environmental impact.
Beyond traditional cannabis testing, terpene analysis is expanding into the flavor‑and‑fragrance, nutraceutical, and functional food sectors, creating new demand vectors for both Mass Spectrometry and hybrid GC‑MS solutions. Regionally, North America retains its leadership, yet Europe is witnessing rapid uptake driven by EU‑wide safety directives, while Asia‑Pacific markets particularly China, Japan, and South Korea are benefitting from rising consumer interest in botanical wellness products. This geographic diversification is reflected in the forecasted regional revenue breakdown, with North America projected to hold 38 % of global sales by 2034, Europe 27 %, and APAC 25 %. As product portfolios broaden and regulatory landscapes evolve, manufacturers are investing heavily in R&D and strategic partnerships to capture emerging pockets of growth.
North America presently holds the dominant share of the Terpene Testing Equipment market. The United States benefits from a mature cannabis‑derived product industry, stringent FDA‑aligned testing regulations, and a concentration of leading manufacturers such as Agilent and Thermo Fisher Scientific. Canada’s federally regulated cannabis market further expands demand for reliable chromatography and mass‑spectrometry platforms, while Mexico’s recent reforms are accelerating early‑stage adoption. Robust R&D investment, a highly skilled workforce, and well‑established distribution networks enable rapid product rollout and continuous upgrades, keeping North America ahead of other regions. Europe, although sizable, lags due to fragmented regulatory approaches, whereas Asia‑Pacific and Latin America are still scaling their testing capacities.
Key Highlights:
Asia‑Pacific is expected to register the fastest compound annual growth rate over the forecast horizon. China’s expanding industrial hemp sector, Japan’s medical cannabis research initiatives, and South Korea’s emerging functional‑food market create a broad base for testing equipment demand. India’s recent policy shifts toward hemp cultivation, combined with a large agricultural base, are prompting investments in portable GC and LC systems. Southeast Asian economies such as Thailand and Malaysia are also adopting stricter quality‑control standards for botanical extracts, further propelling market expansion. While North America remains the largest current market, the sheer scale of production capacity growth and supportive government programs in APAC drive its rapid acceleration.
Key Highlights:
Across all continents, tighter safety regulations and the push for standardized terpene profiling are compelling manufacturers to upgrade or replace legacy analyzers. In North America, the emergence of state‑level cannabis lab accreditation programs mandates the use of validated GC‑MS methods, prompting facilities to invest in newer, more precise instruments. European Union directives on food‑grade botanical extracts are encouraging the adoption of high‑resolution mass spectrometry for traceability. In APAC, recent amendments to hemp‑derived product guidelines are catalyzing rapid procurement of compact, field‑deployable testing solutions. The convergence of regulatory pressure and technological advances such as rapid sample‑injection and data‑analytics integration is therefore a primary growth engine worldwide.
Key Highlights:
Beyond the United States and Canada, Germany and France are solidifying their positions as European hubs due to robust pharmaceutical testing standards and strong R&D funding. In Asia, China and Japan lead investment intensity, with Chinese manufacturers scaling up domestic production and Japanese firms focusing on precision analytical technologies. Brazil’s expanding cannabis research ecosystem and the United Arab Emirates’ strategic diversification into biotech are also attracting notable capital inflows. These nations benefit from a combination of supportive policy environments, growing domestic markets for terpene‑rich products, and increasing collaboration with global equipment suppliers.
Smart agriculture programs that incorporate precision farming and phytochemical monitoring are accelerating the need for reliable terpene analysis. In North America, large‑scale indoor vertical farms are adopting real‑time GC‑MS sensors to optimize flavor profiles, while European Union pilot projects on sustainable hemp cultivation are mandating routine terpene testing for certification purposes. APAC’s “Smart Farm” initiatives, particularly in Japan and South Korea, are integrating automated extraction and analytical lines, creating new demand for high‑throughput instruments. Meanwhile, Latin America’s modernization of cannabis export chains is driving investments in both benchtop and portable testing solutions to meet international quality standards.
Key Highlights:
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers
-> Key players include Agilent, Shimadzu Corporation, Sciex, Thermo Fisher Scientific, PerkinElmer, Waters Corporation, Valenveras, SCION Instruments, among others.
-> Key growth drivers include increasing regulatory scrutiny of cannabis and botanical products, rising demand for quality assurance in the flavor & fragrance industry, and rapid adoption of advanced analytical technologies such as GC‑MS.
-> North America holds the largest share, driven by strong pharmaceutical and cannabis sectors, while Asia‑Pacific is the fastest‑growing region due to expanding agricultural and essential‑oil markets.
-> Emerging trends include integration of AI‑driven data analytics for terpene profiling, portable handheld GC devices for on‑site testing, and sustainable, low‑solvent analytical methods.
| Report Attributes | Report Details |
|---|---|
| Report Title | Terpene Testing Equipment Market, Global Outlook and Forecast 2026-2034 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2025 |
| Forecast Year | 2033 |
| Number of Pages | 105 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions
